Free Trial

10,621 Shares in Addus HomeCare Corporation (NASDAQ:ADUS) Acquired by SG Americas Securities LLC

Addus HomeCare logo with Medical background

SG Americas Securities LLC acquired a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 10,621 shares of the company's stock, valued at approximately $1,050,000. SG Americas Securities LLC owned approximately 0.06% of Addus HomeCare at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Natixis lifted its holdings in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after purchasing an additional 132 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in shares of Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after purchasing an additional 214 shares in the last quarter. Parkside Financial Bank & Trust lifted its holdings in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after purchasing an additional 148 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of Addus HomeCare during the 4th quarter valued at about $77,000. Finally, Harvest Fund Management Co. Ltd bought a new position in shares of Addus HomeCare during the 4th quarter valued at about $86,000. Institutional investors own 95.35% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ADUS. JMP Securities reiterated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Friday. Macquarie reiterated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. Stephens restated an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, Wall Street Zen cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Saturday. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare has a consensus rating of "Buy" and an average target price of $142.57.

View Our Latest Stock Report on Addus HomeCare

Insiders Place Their Bets

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the transaction, the executive vice president now owns 7,796 shares of the company's stock, valued at $896,540. The trade was a 20.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 4.60% of the company's stock.

Addus HomeCare Stock Down 1.2%

NASDAQ ADUS traded down $1.37 during trading on Friday, hitting $113.79. The stock had a trading volume of 195,824 shares, compared to its average volume of 170,637. The company has a market capitalization of $2.09 billion, a PE ratio of 25.69, a P/E/G ratio of 1.61 and a beta of 0.81. The company's 50-day moving average price is $108.91 and its two-hundred day moving average price is $111.90. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The business's quarterly revenue was up 20.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.21 EPS. As a group, sell-side analysts forecast that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines